Skip to main content
Clinical Trials/CTRI/2018/02/012012
CTRI/2018/02/012012
Completed
Phase 4

Balanced controlled hypotensive anaesthesia and optimizing surgical field in middle ear and FESS surgeries with intermittent doses of dexmedetomidine and labetalol- A Randomized clinical trial - BCHMFD

Sri muthukumaran medical colle hospital and research institute0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- ASA I and II patients posted for elective middle ear and FESS surgeries
Sponsor
Sri muthukumaran medical colle hospital and research institute
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sri muthukumaran medical colle hospital and research institute

Eligibility Criteria

Inclusion Criteria

  • 1\.ASA I or II (no or minimal co\-morbid disease)
  • 2\.Patients scheduled for elective middle ear and FESS surgeries

Exclusion Criteria

  • 1\.ASA \> III
  • 2\.History of allergy or contraindications to either Dexmedetomidine or labetalol
  • 3\.Concomitant use of medications which may exaggerate the heart rate response of Dexmedetomidine including digoxin or ß\-adrenergic antagonists.
  • 4\.Coronary artery disease,
  • 5\.ischemic heart disease,
  • 6\.hypertension,
  • 7\.rhythm disturbances,
  • 8\.Bronchial asthma,
  • 9\.diabetes mellitus
  • 10\.history of sleep apnea,

Outcomes

Primary Outcomes

Not specified

Similar Trials